Kocheise, L., Piseddu, I., Vonderlin, J., Tjwa, E. T., Buescher, G., Meunier, L., . . . Schulze, K. (2024). PD-1/PD-L1 immune checkpoint therapy demonstrates favorable safety profile in patients with autoimmune and cholestatic liver disease. Frontiers in immunology, 14, . https://doi.org/10.3389/fimmu.2023.1326078
Chicago-Zitierstil (17. Ausg.)Kocheise, Lorenz, et al. "PD-1/PD-L1 Immune Checkpoint Therapy Demonstrates Favorable Safety Profile in Patients with Autoimmune and Cholestatic Liver Disease." Frontiers in Immunology 14 (2024). https://doi.org/10.3389/fimmu.2023.1326078.
MLA-Zitierstil (9. Ausg.)Kocheise, Lorenz, et al. "PD-1/PD-L1 Immune Checkpoint Therapy Demonstrates Favorable Safety Profile in Patients with Autoimmune and Cholestatic Liver Disease." Frontiers in Immunology, vol. 14, 2024, https://doi.org/10.3389/fimmu.2023.1326078.